Perrigo Company (Nasdaq: PRGO; TASE) announced it received FDA clearance on August 23, 2010 to manufacture infant formula liquid concentrate and ready-to-use products through its partner Kerry Proteins and Nutritionals located in Sainte Claire, Quebec. Perrigo received clearance to market the following new products:

* Milk-Based Infant Formula with ARA and DHA, Concentrate in a 13 oz multilayer high-barrier polypropylene bottle

* Milk-Based Infant Formula with ARA and DHA, Ready-to-Use Infant Formula in an 8 oz multilayer high-barrier polypropylene bottle

* Milk-Based Organic Infant Formula with ARA/DHA, Liquid Ready-to-Feed Infant Formula in an 8 oz multilayer high-barrier polypropylene bottle

Perrigo's Chairman and CEO Joseph C. Papa stated, "We are excited to receive FDA clearance on these new liquid concentrate and ready-to-use products and to expand our portfolio of non-powder infant formula products. This is the first launch of new products since acquiring our infant nutrition business and we look forward to further new product introductions."

Provided by Perrigo Company